MRI of the Spine is the Next Test to Order
For this 62-year-old woman with suspected spinal metastasis from breast cancer, order a full spinal column MRI immediately—this is the gold standard for diagnosing spinal metastases and should be performed within 2 weeks if she has only local back pain, or within 12 hours if there are any neurological symptoms suggesting cord compression. 1
Why MRI First
MRI is superior to all other imaging modalities for demonstrating spinal metastases, epidural extension, and spinal cord compression in a single examination 1. The most recent meta-analysis confirms MRI has the highest diagnostic accuracy with pooled sensitivity of 93% per-patient and 91% per-lesion, along with the highest diagnostic odds ratio among all imaging modalities 2. Both T1- and T2-weighted sequences are required to adequately demonstrate spinal metastases and epidural disease 1.
Key advantages of MRI:
- Highest sensitivity for bone marrow infiltration
- Best visualization of epidural extension and cord compression
- Can assess spinal instability using the SINS framework
- Single examination covers the entire spinal column 1, 3
When to Consider Biopsy
Biopsy is NOT the next step in this case because the patient has a known 12-year history of breast cancer. Biopsy is reserved for patients with suspected spinal metastases of unknown origin where histological diagnosis is needed before treatment can start 1.
However, consider biopsy if:
- The imaging findings are atypical for metastatic breast cancer
- There's diagnostic uncertainty about whether this represents recurrence versus a new primary malignancy
- Treatment decisions would fundamentally change based on histological confirmation
- The patient has been disease-free for an extended period and recurrence seems unlikely
Predictive factors that increase likelihood of malignancy on biopsy include history of malignant tumors (which this patient has), presence of pedicle lesions, and extravertebral lesions 4.
Role of PET Scan
PET scan is not the appropriate next test for several critical reasons:
- PET/CT has lower sensitivity (82% per-patient, 92% per-lesion) compared to MRI 2
- FDG-PET has variable performance depending on breast cancer phenotype—it notably has poor sensitivity for invasive lobular carcinoma due to low FDG avidity 5
- PET cannot adequately assess spinal cord compression or mechanical instability, which are oncologic emergencies 1
- One case report demonstrated PET-CT completely missing an occult breast primary that was detected on contrast-enhanced MRI 5
PET/CT may be useful later for whole-body staging assessment after the spinal disease is characterized, but it should not delay or replace MRI for evaluating suspected spinal metastases 3.
Urgent Timing Considerations
The guideline sets clear deadlines based on clinical presentation 1:
- Within 12 hours: If any neurological symptoms present (leg weakness, difficulty controlling legs, numbness radiating from chest/groin/legs, inability to walk)
- Within 2 weeks: If only local back pain without neurological deficits
Common pitfall: Conventional x-rays, CT scans, or bone scintigraphy cannot exclude spinal metastases and should not be used as the primary diagnostic test 1. CT is useful later for assessing cortical destruction and mechanical instability but is less sensitive for early marrow disease 3.
After MRI Results
Once MRI characterizes the extent of disease, treatment selection depends on:
- Estimated survival
- Spinal stability (assessed using SINS)
- Presence/absence of metastatic epidural spinal cord compression (graded using Bilsky ESCC scale)
- Patient's neurological status 1
Radiotherapy is generally first-line for symptomatic spinal metastases, while surgery is preferred for spinal instability or neurological deterioration 1.